4726 fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Mycenax Biotech, Inc. engages in the research and development, manufacture, and sale of biopharmaceutical products. It offers new protein molecules and biosmilars. It provides contract development and manufacturing organization services including cell line development, process development, analytics and quality control, good manufacturing practice, aseptic fill and finish, and regulatory compliance services. The company was founded by Ching Ying Chen, Ching Chu Feng and Yi Hsu Huang on September 28, 2001 and is headquartered in Miaoli, Taiwan.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
No dividends
4726 has never paid dividends and has no current plans to do so.
Financial health
Financial position and solvency of the company